U.S. Markets open in 34 hrs, 17 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,464.40 | 30.69 | 0.29% |
| NASDAQ | 2,176.05 | 6.87 | 0.32% |
| S&P 500 | 1,110.63 | 4.98 | 0.45% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.48 09:31 AM EST | |
|---|---|---|
| Day High | 1.525 12:36 PM EST |
|
| Range | 0.04 |
| Volume | 874,178 | |
|---|---|---|
| 30-Day Avg Vol | 1.48 M |
|
| Difference | -41.13% |
| Market Cap | 163.44 M | |
|---|---|---|
| Mkt Cap Chg | -1.10 M |
| Shares Out | 110.43 M | |
|---|---|---|
| % Shrs Traded | 0.79% | |
| 1yr EPS Est | -0.225 |
| 52-Wk Low | 0.46 | |
|---|---|---|
| 52-Wk High | 2.73 |
|
| Range | 2.27 |
| Prev Close | 1.49 11/24/09 | |
|---|---|---|
| Today's Open | 1.49 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 7.52 M |
| Revenue (LFY) | 21.25 M | |
|---|---|---|
| Earnings (LFY) | -23.95 M | |
| Earnings (MRQ) | -8.09 M | |
| Next Earn Est | -0.045 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -0.34 | |
| 1yr EPS Growth | 31.82% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -6.00 | |
| PEG Ratio | — | |
| Return on Equity | -107.83 | |
| Beta | 1.74 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
AVI BioPharma has a sixth sense about antisense. A developer of biopharmaceutical compounds, AVI's investigational therapies are based on its NeuGene antisense drug technology, which can halt disease processes ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.045 3/8/10 | — — |
—
—
|
| Last Quarter | -0.065 9/30/09 | -0.08 9/30/09 |
-0.015
Missed
|
| 2 Quarters Ago | -0.02 6/30/09 | -0.23 6/30/09 |
-0.21
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 6.35 M | 21.26 M |
| Gross Profit | -1.85 M | 19.79 M |
| Operating Income | -2.92 M | -17.54 M |
| Net Income | -8.09 M | -23.95 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts